Republican senators urge more regulations on abortion pill in Senate hearing

Jan 15, 2026 / 17:10 pm

As the Food and Drug Administration (FDA) continues its review of the abortion pill mifepristone, Republican lawmakers are repeating calls for stronger federal regulations of the drug.

The Senate Health, Education, Labor, and Pensions Committee, chaired by Sen. Bill Cassidy, R-Louisiana, held a hearing about the drugs Jan. 14. Republican lawmakers called for stricter rules, while Democratic lawmakers advocated for easy access to the drugs.

Cassidy, who is a medical doctor, urged Health and Human Services Secretary Robert Kennedy Jr. and FDA Commissioner Martin Makary to complete the safety review of mifepristone promised during their confirmation hearings.

“Republican members of this committee and many other senators expect an answer,” Cassidy said. “At an absolute minimum, the previous in-person safeguards must be restored immediately.”

Cassidy expressed concern about the deregulation of mifepristone under former President Barack Obama in 2016 and former President Joe Biden in 2023 and said they have made women less safe.

In 2016, the FDA lowered the number of mandatory in-person doctor visits needed to obtain mifepristone from three to one and then fully eliminated required in-person visits in 2023. In 2016, the FDA stopped requiring doctors to report adverse events and ended rules requiring mifepristone to be dispensed by a physician and taken in a doctor’s office. Another 2016 rule change ended the mandatory follow-up visit and another 2023 rule change authorized delivery of the drug through the mail.

“It’s only through a proper medical examination that a doctor can determine a baby’s gestational age, ensure a woman does not have an ectopic pregnancy, and be sure the abortion will not jeopardize future fertility,” Cassidy said. “I’m a doctor, and if the first rule is do no harm, the way things work today has the potential to do a lot of harm.”

Speaking to “EWTN News Nightly” prior to the hearing, Cassidy said: “There’s some women at higher risk for complications … and the doctor interviewing her would be able to see that.”

He said President Donald Trump’s administration should suspend the use of mifepristone or at least reimpose previous safeguards.

An HHS spokesperson said the department “is conducting a study of reported adverse events associated with mifepristone to assess whether the FDA’s risk mitigation program continues to provide appropriate protections for women.”

“The FDA’s scientific review process is thorough and takes the time necessary to ensure decisions are grounded in gold-standard science,” the spokesperson said. “Dr. Makary is upholding that standard as part of the Department’s commitment to rigorous, evidence-based review.”

Dr. Monique Chireau Wubbenhorst, a practicing OB-GYN and research assistant for Notre Dame’s Center for Ethics and Culture, testified to the committee about potential harms of mifepristone and the added risks caused by the deregulation.

“The different risks that are associated with abortion are bleeding, infection, hemorrhage, [and a] need for transfusion,” she said, adding that taking abortion drugs while having an undiagnosed ectopic pregnancy can be life-threatening.

Apart from the medical risks, Wubbenhorst also said the lack of oversight exacerbates problems with human trafficking, child sex abuse, and domestic violence: “Abusers have been known to force abortion pills down women’s throats, put them in their drinks, and insert them into their bodies,” she said.

Louisiana Attorney General Liz Murrill told senators the deregulation of the Biden administration was a “purely political” decision, as opposed to a medical one, and she spoke about women in her state being coerced into taking mifepristone and cases of adverse events that she blames on the deregulation.

“A few examples from Louisiana include a woman who was coerced to abort her wanted baby, multiple [examples] of that, by partners or parents, a pregnant woman who took pills … mailed to her at 20 weeks’ gestation and ended up in the emergency room while her baby was left in a dumpster, [and regarding] another 20-week-old pregnancy, the baby was found recovered in a toilet,” she said.

Last year, Murrill sued the FDA over the deregulation after a resident, Rosalie Markezich, said her boyfriend forced her to take an abortion pill that was obtained through the mail.

Democratic lawmakers rejected calls for stricter regulations, with ranking member Bernie Sanders, an independent from Vermont, saying the meeting is “not about the safety of a drug” and pointed to medical groups like the American Medical Association vouching for its safety.

“It is about the ongoing effort of my friends in the Republican Party to deny the women of this country the basic right to control their own bodies,” Sanders said. “That is what this hearing is about.”

Nisha Verma, an OB-GYN and fellow at Physicians for Reproductive Health, testified that the drugs are safe for women and can help women recovering from a miscarriage. She said her patients who suffer from miscarriages “are at risk” because of restrictions in certain states.

“My patients are at risk because of restrictions on abortion and cuts to Medicaid,” she said. “They are at risk because of decreased funding to clinics that provide preventative care and cancer screenings and fears about whether they can safely go to the hospital based on their immigration status.”

Kennedy ordered a review of mifepristone last year, and the federal government has yet to reestablish any safeguards on the drug. Rather, the FDA approved a generic version of mifepristone in October, sparking backlash from Republican lawmakers and pro-life organizations.